Health Briefs July 1, 2014
Palisade teens to serve on drug prevention council
A new Colorado drug-prevention organization announced the members of its Teen Action Council for the 2014-2015 school year, including two students from the Grand Valley.
Kiyanna Maestas and Kiara Morrison, both of Palisade High School, were selected to work with the Rise Above Colorado program.
Most of the 24 high school students from across the state who are involved in the group have personally seen the negative impact drug abuse can have and they want to serve as a positive voice in their communities for choosing healthy alternatives, program officials said in a news release.
In addition to school and community outreach efforts in their respective communities, each of the teens will help spread the word about the dangers of drug abuse through peer to peer activities.
Maestas and will share with fellow students:
■ The issue of teen drug abuse from their eyes
■ Why they chose to be involved with Rise Above Colorado
■ How they will have an impact on their communities through their work with Rise Above Colorado.
For more information, call 303-495-2999. Study: 3D mammography improves outcomes
Digital breast tomosynthesis, or 3-D mammography, finds significantly more invasive cancers and reduces unnecessary callbacks, according to a large, retrospective study published in The Journal of the American Medical Association. Locally, the technology is available at Family Health West in Fruita, hospital officials said.
The study, which includes data from Invision Sally Jobe as well as 12 other centers nationwide, looked at nearly half a million mammograms. When tomosynthesis is used in addition to digital screening mammography, the study found:
■ A 41 percent increase in invasive cancer detected.
■ A 15 percent decrease in unnecessary callbacks for false alarms.
■ A 29 percent increase in the detection of all breast cancers.
Invision Sally Jobe was the first breast center in Colorado to offer 3-D mammography as part of an early clinical trial of tomosynthesis in 2009.
In 2011, the U.S. Food and Drug Administration approved tomosynthesis in combination with standard digital mammography for breast cancer screening.